Results 11 to 20 of about 1,577,570 (335)
Background The COVID-19 pandemic has considerably disrupted nearly all aspects of daily life, including healthcare delivery and clinical research. Because pragmatic clinical trials are often embedded within healthcare delivery systems, they may be at ...
Emily C. O’Brien +6 more
doaj +2 more sources
Background The clinical research enterprise is not producing the evidence decision makers arguably need in a timely and cost effective manner; research currently involves the use of labor-intensive parallel systems that are separate from clinical care ...
Kevin P. Weinfurt +20 more
doaj +2 more sources
The time is now: role of pragmatic clinical trials in guiding response to global pandemics
Along with its heavy toll of morbidity and mortality, the coronavirus disease 2019 (COVID-19) pandemic exposed several limitations of the current global research response.
Aws Almufleh, Jacob Joseph
doaj +2 more sources
Principles and procedures for data and safety monitoring in pragmatic clinical trials
Background All clinical trial investigators have ethical and regulatory obligations to monitor participant safety and trial integrity. Specific procedures for meeting these obligations, however, may differ substantially between pragmatic trials and ...
Gregory E. Simon +5 more
doaj +2 more sources
Ardith Z. Doorenbos, Duckhee Chae
openaire +3 more sources
Pragmatic clinical trials and the consent process
Pragmatic clinical trials (PCTs) are a relatively new methodological approach to the execution of clinical research that can increase research efficiency and provide access to unique data.
Blake Murdoch, Timothy Caulfield
doaj +2 more sources
Intervention delivery for embedded pragmatic clinical trials: Development of a tool to measure complexity. [PDF]
BACKGROUND Conducting an embedded pragmatic clinical trial in the workflow of a healthcare system is a complex endeavor. The complexity of the intervention delivery can have implications for study planning, ability to maintain fidelity to the ...
Staman KL +12 more
europepmc +2 more sources
Ethical considerations for sharing aggregate results from pragmatic clinical trials. [PDF]
A growing literature has explored the ethical obligations and current practices related to sharing aggregate results with research participants. However, no prior work has examined these issues in the context of pragmatic clinical trials.
Morain SR +9 more
europepmc +2 more sources
Ethics challenges in sharing data from pragmatic clinical trials. [PDF]
Numerous arguments have been advanced for broadly sharing de-identified, participant-level clinical trials data, and trial sponsors and journals are increasingly requiring it. However, data sharing in pragmatic clinical trials presents ethical challenges
Morain SR +3 more
europepmc +2 more sources
Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials? [PDF]
Clinicians have good moral and professional reasons to contribute to pragmatic clinical trials (PCTs). We argue that clinicians have a defeasible duty to participate in this research that takes place in usual care settings and does not involve ...
Garland A, Morain S, Sugarman J.
europepmc +2 more sources

